Abstract
Staphylococcus aureus (S. aureus) is an important foodborne and environmental pathogen that can produce toxins in foods and cause infections in soft tissues. S. aureus that have developed resistance to the conventional antimicrobials are commonly called Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA). Their prevalence is believed to be due to the widespread use of antibiotics. Therefore, natural antimicrobials are in urgent demand as alternatives to conventional antibiotics to treat S. aureus infections. In this review, natural antimicrobials from plant, animal and microbiological origins are discussed, including their mode of action and mechanisms of bacterial resistance, major components, chemical structure, effectiveness, synergistic effects and future prospects.
Keywords: Antibiotic resistance, MRSA, Natural antimicrobials, S. aureus, toxins, cause infections in soft tissues., Methicillin-Resistant, Vancomycin-Resistant, life-threatening infections, staphylococcal gastroenteritis, staphylococcal food poisoning, abdominal cramping, nausea, muscle cramping, endocarditis
Current Pharmaceutical Biotechnology
Title: Use of Natural Antimicrobials from a Food Safety Perspective for Control of Staphylococcus aureus
Volume: 12 Issue: 8
Author(s): Min Li, Arunachalam Muthaiyan, Corliss A. O'Bryan, John E. Gustafson, Y. Li, Philip G. Crandall and Steven C. Ricke
Affiliation:
Keywords: Antibiotic resistance, MRSA, Natural antimicrobials, S. aureus, toxins, cause infections in soft tissues., Methicillin-Resistant, Vancomycin-Resistant, life-threatening infections, staphylococcal gastroenteritis, staphylococcal food poisoning, abdominal cramping, nausea, muscle cramping, endocarditis
Abstract: Staphylococcus aureus (S. aureus) is an important foodborne and environmental pathogen that can produce toxins in foods and cause infections in soft tissues. S. aureus that have developed resistance to the conventional antimicrobials are commonly called Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA). Their prevalence is believed to be due to the widespread use of antibiotics. Therefore, natural antimicrobials are in urgent demand as alternatives to conventional antibiotics to treat S. aureus infections. In this review, natural antimicrobials from plant, animal and microbiological origins are discussed, including their mode of action and mechanisms of bacterial resistance, major components, chemical structure, effectiveness, synergistic effects and future prospects.
Export Options
About this article
Cite this article as:
Li Min, Muthaiyan Arunachalam, A. O'Bryan Corliss, E. Gustafson John, Li Y., G. Crandall Philip and C. Ricke Steven, Use of Natural Antimicrobials from a Food Safety Perspective for Control of Staphylococcus aureus, Current Pharmaceutical Biotechnology 2011; 12 (8) . https://dx.doi.org/10.2174/138920111796117283
DOI https://dx.doi.org/10.2174/138920111796117283 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus
Current Protein & Peptide Science Novel Approaches to Control Biofilm Infections
Current Medicinal Chemistry Therapeutic Potential of γ -Secretase Inhibitors and Modulators
Current Topics in Medicinal Chemistry Proteomics of Biofilm Bacteria
Current Proteomics Driving Forces of Mechanisms Regulating Oxacillin-Resistance Phenotypes of MRSA: Truly Oxacillin-Susceptible mecA-Positive Staphylococcus aureus Clinical Isolates also Exist
Current Pharmaceutical Design <i>Corynebacterium Striatum</i>, an Emerging Nosocomial Pathogen: Case Reports
Infectious Disorders - Drug Targets Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Current Pharmaceutical Design Indications of Anti-Inflammatory Drugs in Cardiac Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
Current Drug Abuse Reviews Postoperative Complications in Hemorrhoidal Disease and Special Conditions
Reviews on Recent Clinical Trials The Perils, Pitfalls and Opportunities of Using High Sensitivity Cardiac Troponin
Current Medicinal Chemistry CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Prokaryotic Substrate-Binding Proteins as Targets for Antimicrobial Therapies
Current Drug Targets Neuronal Regulation of Aortic Valve Cusps
Current Vascular Pharmacology Polyproline and Triple Helix Motifs in Host-Pathogen Recognition
Current Protein & Peptide Science Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Current Cardiology Reviews Current Research on Opioid Receptor Function
Current Drug Targets Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives
Medicinal Chemistry Non-Steroidal Targets in the Diagnosis and Treatment of Endometriosis
Current Medicinal Chemistry